RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Boston Scientific Stock

Boston Scientific Revenue 2025

Boston Scientific Revenue

20.01 B USD

Ticker

BSX

ISIN

US1011371077

WKN

884113

In 2025, Boston Scientific's sales reached 20.01 B USD, a 19.47% difference from the 16.75 B USD sales recorded in the previous year.

The Boston Scientific Revenue history

YEARREVENUE (undefined USD)GROSS MARGIN (%)
2030e3038,20
2029e27.8241,18
2028e25.6944,60
2027e24.4146,94
2026e22.1951,64
2025e20.0157,26
202416.7568,41
202314.2469,65
202212.6869,00
202111.8969,04
20209.9165,24
201910.7470,67
20189.8271,13
20179.0571,09
20168.3970,56
20157.4870,42
20147.3868,88
20137.1467,60
20127.2565,60
20117.6263,25
20107.8164,34
20098.1966,21
20088.0566,81
20078.3669,56
20067.8268,83
20056.2874,33

Boston Scientific Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Boston Scientific, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Boston Scientific from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Boston Scientific’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Boston Scientific. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Boston Scientific’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Boston Scientific’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Boston Scientific’s growth potential.

Boston Scientific Revenue, EBIT and net profit per share

DateBoston Scientific RevenueBoston Scientific EBITBoston Scientific Net Income
2030e30 B undefined0 undefined7.41 B undefined
2029e27.82 B undefined8.13 B undefined6.7 B undefined
2028e25.69 B undefined7.43 B undefined6.04 B undefined
2027e24.41 B undefined6.77 B undefined5.57 B undefined
2026e22.19 B undefined6.1 B undefined4.95 B undefined
2025e20.01 B undefined5.45 B undefined4.38 B undefined
202416.75 B undefined3.01 B undefined1.85 B undefined
202314.24 B undefined2.43 B undefined1.57 B undefined
202212.68 B undefined2.07 B undefined642 M undefined
202111.89 B undefined2.11 B undefined985 M undefined
20209.91 B undefined902 M undefined-115 M undefined
201910.74 B undefined1.82 B undefined4.7 B undefined
20189.82 B undefined1.74 B undefined1.67 B undefined
20179.05 B undefined1.67 B undefined104 M undefined
20168.39 B undefined1.34 B undefined347 M undefined
20157.48 B undefined924 M undefined-239 M undefined
20147.38 B undefined1.04 B undefined-119 M undefined
20137.14 B undefined903 M undefined-121 M undefined
20127.25 B undefined961 M undefined-4.07 B undefined
20117.62 B undefined1.02 B undefined441 M undefined
20107.81 B undefined993 M undefined-1.07 B undefined
20098.19 B undefined1.25 B undefined-1.03 B undefined
20088.05 B undefined1.27 B undefined-2.04 B undefined
20078.36 B undefined1.19 B undefined-495 M undefined
20067.82 B undefined1.23 B undefined-3.58 B undefined
20056.28 B undefined2.02 B undefined628 M undefined

Boston Scientific stock margins

The Boston Scientific margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Boston Scientific. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Boston Scientific.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Boston Scientific's sales revenue. A higher gross margin percentage indicates that the Boston Scientific retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Boston Scientific's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Boston Scientific's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Boston Scientific's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Boston Scientific. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Boston Scientific's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Boston Scientific Margin History

Boston Scientific Gross marginBoston Scientific Profit marginBoston Scientific EBIT marginBoston Scientific Profit margin
2030e68.41 %0 %24.72 %
2029e68.41 %29.22 %24.08 %
2028e68.41 %28.92 %23.52 %
2027e68.41 %27.71 %22.83 %
2026e68.41 %27.48 %22.33 %
2025e68.41 %27.25 %21.89 %
202468.41 %17.94 %11.06 %
202369.65 %17.05 %11.03 %
202269 %16.33 %5.06 %
202169.04 %17.77 %8.29 %
202065.24 %9.1 %-1.16 %
201970.67 %16.96 %43.78 %
201871.13 %17.7 %17.01 %
201771.09 %18.45 %1.15 %
201670.56 %15.98 %4.14 %
201570.42 %12.36 %-3.2 %
201468.88 %14.02 %-1.61 %
201367.6 %12.64 %-1.69 %
201265.6 %13.26 %-56.12 %
201163.25 %13.33 %5.79 %
201064.34 %12.72 %-13.64 %
200966.21 %15.32 %-12.52 %
200866.81 %15.79 %-25.29 %
200769.56 %14.28 %-5.92 %
200668.83 %15.68 %-45.74 %
200574.33 %32.21 %10 %

Boston Scientific Aktienanalyse

What does Boston Scientific do?

Boston Scientific Corp. is a global medical technology company specializing in the development and manufacturing of innovative solutions for medical challenges and needs. The company was founded in 1979 and has since been dedicated to meeting the individual needs of patients and medical professionals with innovative products. The history of Boston Scientific began in the 1960s when French engineer Jean-Marc Simon started developing pacemakers at the University of Minnesota. In 1969, Medtronic acquired Simon's pacemaker development, leading to the founding of Boston Scientific. From the beginning, the company focused on the production of cardiovascular implants, including pacemakers, implanted defibrillators, and stents. In the following years, the company achieved continued growth through acquisitions of competitors and advancements in research and development, particularly in the field of minimally invasive procedures. Today, Boston Scientific is a globally leading provider of innovative medical devices and solutions used in various areas of healthcare. Boston Scientific's business model is based on meeting the needs of patients, medical professionals, and healthcare policymakers in order to improve healthcare. The company works closely with doctors, hospitals, nursing facilities, and research institutions to continuously develop innovative solutions for various diseases and conditions. Boston Scientific has five business segments: Cardiovascular Systems, Interventional Oncology and Neuromodulation, Urology and Women's Health, Medical Oncology, and Endoscopy. The Cardiovascular Systems segment includes products and solutions for cardiovascular surgery, including pacemakers, implanted defibrillators, and catheters. The company is also involved in endovascular surgery, offering innovative stent and catheter systems for the treatment of aneurysms and arterial occlusive disease. The Interventional Oncology and Neuromodulation segment includes solutions for the minimally invasive treatment of cancer and chronic pain through catheter and implant systems. For example, Boston Scientific offers intensity-controlled radiofrequency ablation and neuromodulation procedures. The Urology and Women's Health segment includes products for the treatment and diagnosis of urogenital system disorders, including incontinence, urinary incontinence, and genital diseases. Boston Scientific offers innovative solutions for women, such as the treatment of urinary incontinence or the removal of uterine fibroids. The Medical Oncology segment includes products for the diagnosis and treatment of cancer, including in vitro diagnostics and novel treatments such as chemotherapy delivery technology. The Endoscopy segment includes endoscopic solutions, including the diagnosis and therapy of digestive tract, chest, and lung disorders. Boston Scientific's product portfolio is diverse and includes numerous innovative medical devices and systems designed to meet the needs of patients and medical professionals. Some of the notable products of the company include: - The Implantable Cardioverter-Defibrillator (ICD) is an innovative device that can treat heart rhythm disorders through the use of a remote control. - Drug-Eluting Stents are stents that deliver medication directly at the site of narrowing, promoting blood flow and helping to keep the artery open. - The Synergy is a top-of-the-line stent that has both a lower mortality rate and a higher success rate than conventional stents. - The Venus-EP Steerable Sheath is an advanced catheter that allows physicians unique navigation within the heart chambers. - The Precision is a catheter that sends impulses to the heart for the diagnosis and treatment of atrial fibrillation. - The Transcend is a pacemaker that combines traditional pacemaker function with a sensor that actively supports the patient during physical activity. - The Symphion is an innovative system for laparoscopic surgery that enables minimally invasive surgical procedures in women. In conclusion, Boston Scientific Corp. is a globally leading provider of innovative medical devices and solutions that run like a common thread through its various business segments. With a significant focus on research and development, the company offers a wide range of products to ensure that patients worldwide have access to innovative medical care. Through pioneering innovations, the development of new technologies, and collaboration with medical professionals, Boston Scientific will continue to defend its position as a leading provider of medical solutions worldwide. Boston Scientific ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Revenue Details

Understanding Boston Scientific's Sales Figures

The sales figures of Boston Scientific originate from the total revenue accrued from goods sold or services provided during a specific time period. These numbers are a direct reflection of the company’s ability to translate its products or services into revenue, indicating the demand and market presence.

Year-to-Year Comparison

Analyzing Boston Scientific’s yearly sales data offers insights into the company’s growth and stability. An increase in sales suggests a growing demand for its offerings, efficient marketing, or expansion into new markets. Conversely, a decline might indicate market saturation, increased competition, or less effective strategies.

Impact on Investments

Investors often scrutinize Boston Scientific's sales data to evaluate its financial health and growth prospects. Consistent sales growth can be a promising indicator of the company’s profitability and potential return on investment, influencing stock prices and investor confidence.

Interpreting Sales Fluctuations

Increases in Boston Scientific’s sales indicate market growth, innovation, or effective marketing, often leading to a surge in stock prices. A decline, however, can signal challenges requiring strategic adjustments to enhance market share and profitability.

Frequently Asked Questions about Boston Scientific stock

How much revenue did Boston Scientific generate this year?

Boston Scientific has achieved a revenue of 20.01 B USD this year.

How much was the turnover of the company Boston Scientific compared to the previous year?

The revenue of Boston Scientific has increased by 19.47% increased compared to the previous year.

What does revenue mean for investors?

The revenue of a company is an important indicator of its financial performance and attractiveness for investors.

Which factors influence the revenue of Boston Scientific?

The revenue of Boston Scientific is influenced by various factors, including the demand for its products and services, market conditions, and prices.

How is the revenue of Boston Scientific measured?

Revenue is typically measured in units referring to the sale of goods and services provided by the company.

How does an increase in sales affect investments?

An increase in revenue can prompt investors to invest more money in the company as it serves as a positive signal for its financial performance and growth prospects.

What are the possible risks associated with a declining revenue?

A decline in revenue can prompt investors to invest less money in the company, as it is a negative signal for its financial performance and growth prospects.

Why is the sales revenue of Boston Scientific so important for investors?

The revenue of Boston Scientific is an important indicator of financial performance and attractiveness for investors.

What strategic measures can a company take to increase revenue?

A company can take various strategic measures to increase revenue, including developing new products and services, introducing new pricing models, and expanding into new markets.

How much dividend does Boston Scientific pay?

Over the past 12 months, Boston Scientific paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Boston Scientific is expected to pay a dividend of 0 USD.

What is the dividend yield of Boston Scientific?

The current dividend yield of Boston Scientific is .

When does Boston Scientific pay dividends?

Boston Scientific pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Boston Scientific?

Boston Scientific paid dividends every year for the past 0 years.

What is the dividend of Boston Scientific?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Boston Scientific located?

Boston Scientific is assigned to the 'Health' sector.

Wann musste ich die Aktien von Boston Scientific kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Boston Scientific from 8/1/2025 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 8/1/2025.

When did Boston Scientific pay the last dividend?

The last dividend was paid out on 8/1/2025.

What was the dividend of Boston Scientific in the year 2024?

In the year 2024, Boston Scientific distributed 0 USD as dividends.

In which currency does Boston Scientific pay out the dividend?

The dividends of Boston Scientific are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

The Boston Scientific stock can be added to a savings plan with the following providers: Trade Republic

Andere Kennzahlen von Boston Scientific

Our stock analysis for Boston Scientific Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Boston Scientific Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.